| Identification | Back Directory | [Name]
FMOC-D-ORN(BOC)-OH | [CAS]
118476-89-4 | [Synonyms]
Fmoc-D-Orn(Boc)
MOC-D-ORN(BOC)-OH
FMOC-D-ORN(BOC)-OH
FMOC-D-ORNITHINE(BOC)-OH
Fmoc-D-Orn(Boc)-OH, ≥98%
N-Fmoc-N’-Boc-D-Ornithine
Fmoc-(Nd-Boc)-D-ornithine
Fmoc-(N'-Boc)-D-ornithine
N5-Boc-N2-Fmoc-D-ornithine
Nα-Fmoc-Nδ-Boc-D-ornithine
FMOC-(N-DELTA-BOC)-D-ORNITHINE
Fmoc-D-Orn(Boc)-OH Novabiochem
N^d-Boc-N^a-FMoc-D-ornithine, 95%
N-ALPHA-FMOC-N-D-T-BOC-D-ORNITHINE
Ndelta-Boc-Nalpha-Fmoc-D-ornithine
N-alpha-Fmoc-N-delta-Boc-D-ornithine
N-ALPHA-FMOC-N-DELTA-T-BOC-D-ORNITHINE
Nα-Fmoc-Nδ-Boc-D-ornithine≥ 99% (HPLC)
REF DUPL: N-alpha-Fmoc-N-delta-Boc-D-ornithine
(9H-Fluoren-9-yl)MethOxy]Carbonyl D-Orn(Boc)-OH
9-fluorenylmethoxycarbonyl-L-ornithine-tert-butoxycarbonyl
N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-DELTA-T-BUTOXYCARBONYL-D-ORNITHINE
N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-delta-t-butyloxycarbonyl-D-ornithine
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-GAMMA-(T-BUTYLOXYCARBONYL)-D-ORNITHINE
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-DELTA-TERT-BUTYLOXYCARBONYL-D-ORNITHINE
D-Ornithine, N5-[(1,1-dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-
(R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-5-((tert-butoxycarbonyl)aMino)pentanoic acid
(2R)-5-{[(tert-butoxy)carbonyl]amino}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoic acid
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid | [Molecular Formula]
C25H30N2O6 | [MDL Number]
MFCD00077065 | [MOL File]
118476-89-4.mol | [Molecular Weight]
454.52 |
| Chemical Properties | Back Directory | [Boiling point ]
679.0±55.0 °C(Predicted) | [density ]
1.226±0.06 g/cm3(Predicted) | [storage temp. ]
Store at RT. | [form ]
Powder | [pka]
3.85±0.21(Predicted) | [color ]
Yellow | [CAS DataBase Reference]
118476-89-4 |
| Hazard Information | Back Directory | [Chemical Properties]
White crystalline powder | [Uses]
Fmoc-D-Orn(Boc)-OH is a reagent used for the synthesis of bisquinoline analogs with antileishmanial and antimicrobial activities against a panel of pathogenic bacteria and fungi. | [reaction suitability]
reaction type: Fmoc solid-phase peptide synthesis |
|
|